 |
|
CLINICIAN'S CORNER
Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes
A Systematic Review and Meta-analysis
Eric L. Ding, BA;
Yiqing Song, MD, ScD;
Vasanti S. Malik, MSc;
Simin Liu, MD, ScD
JAMA. 2006;295:1288-1299.
Context Inconsistent data suggest that endogenous sex hormones may have a role in sex-dependent etiologies of type 2 diabetes, such that hyperandrogenism may increase risk in women while decreasing risk in men.
Objective To systematically assess studies evaluating the association of plasma levels of testosterone, sex hormone–binding globulin (SHBG), and estradiol with risk of type 2 diabetes.
Data Sources Systematic search of EMBASE and MEDLINE (1966-June 2005) for English-language articles using the keywords diabetes, testosterone, sex-hormone-binding-globulin, and estradiol; references of retrieved articles; and direct author contact.
Study Selection From 80 retrieved articles, 43 prospective and cross-sectional studies were identified, comprising 6974 women and 6427 men and presenting relative risks (RRs) or hormone levels for cases and controls.
Data Extraction Information on study design, participant characteristics, hormone levels, and risk estimates were independently extracted by 2 investigators using a standardized protocol.
Data Synthesis Results were pooled using random effects and meta-regressions. Cross-sectional studies indicated that testosterone level was significantly lower in men with type 2 diabetes (mean difference, –76.6 ng/dL; 95% confidence interval [CI], –99.4 to –53.6) and higher in women with type 2 diabetes compared with controls (mean difference, 6.1 ng/dL; 95% CI, 2.3 to 10.1) (P<.001 for sex difference). Similarly, prospective studies showed that men with higher testosterone levels (range, 449.6-605.2 ng/dL) had a 42% lower risk of type 2 diabetes (RR, 0.58; 95% CI, 0.39 to 0.87), while there was suggestion that testosterone increased risk in women (P = .06 for sex difference). Cross-sectional and prospective studies both found that SHBG was more protective in women than in men (P .01 for sex difference for both), with prospective studies indicating that women with higher SHBG levels (>60 vs 60 nmol/L) had an 80% lower risk of type 2 diabetes (RR, 0.20; 95% CI, 0.12 to 0.30), while men with higher SHBG levels (>28.3 vs 28.3 nmol/L) had a 52% lower risk (RR, 0.48; 95% CI, 0.33 to 0.69). Estradiol levels were elevated among men and postmenopausal women with diabetes compared with controls (P = .007).
Conclusions This systematic review indicates that endogenous sex hormones may differentially modulate glycemic status and risk of type 2 diabetes in men and women. High testosterone levels are associated with higher risk of type 2 diabetes in women but with lower risk in men; the inverse association of SHBG with risk was stronger in women than in men.
Author Affiliations: Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass (Drs Song and Liu and Mr Ding); Departments of Epidemiology (Dr Liu and Mr Ding) and Nutrition (Mssrs Ding and Malik), Harvard School of Public Health, Boston; and Program on Genomics and Nutrition, Department of Epidemiology, UCLA School of Public Health, Los Angeles, Calif (Dr Liu).
RELATED LETTERS
Endogenous Sex Hormones and Type 2 Diabetes Risk
Gerald B. Phillips
JAMA. 2006;296(2):168-169.
EXTRACT
| FULL TEXT
Endogenous Sex Hormones and Type 2 Diabetes Risk
Carolyn A. Bondy
JAMA. 2006;296(2):169.
EXTRACT
| FULL TEXT
Endogenous Sex Hormones and Type 2 Diabetes Risk—Reply
Eric L. Ding, Yiqing Song, and Simin Liu
JAMA. 2006;296(2):169-170.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Weight and Diabetes
Sharon Parmet, Cassio Lynm, and Richard M. Glass
JAMA. 2006;295(11):1330.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes
Grossmann et al.
J. Clin. Endocrinol. Metab. 2008;93:1834-1840.
ABSTRACT
| FULL TEXT
Secondary Effects of Antipsychotics: Women at Greater Risk Than Men
Seeman
Schizophr Bull 2008;0:sbn023v1-sbn023.
ABSTRACT
| FULL TEXT
Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health--National Heart, Lung, and Blood Institute Sponsored Women's Ischemia Syndrome Evaluation
Shaw et al.
J. Clin. Endocrinol. Metab. 2008;93:1276-1284.
ABSTRACT
| FULL TEXT
Low Serum Testosterone and Mortality in Older Men
Laughlin et al.
J. Clin. Endocrinol. Metab. 2008;93:68-75.
ABSTRACT
| FULL TEXT
Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
Khaw et al.
Circulation 2007;116:2694-2701.
ABSTRACT
| FULL TEXT
Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women
Rose et al.
Endocr. Rev. 2007;28:763-777.
ABSTRACT
| FULL TEXT
Acute Sex Steroid Withdrawal Reduces Insulin Sensitivity in Healthy Men with Idiopathic Hypogonadotropic Hypogonadism
Yialamas et al.
J. Clin. Endocrinol. Metab. 2007;92:4254-4259.
ABSTRACT
| FULL TEXT
Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies
Larsson and Wolk
Am. J. Clin. Nutr. 2007;86:556-565.
ABSTRACT
| FULL TEXT
Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists
Collins et al.
Eur Heart J 2007;28:2028-2040.
ABSTRACT
| FULL TEXT
Serum Estrogen, But Not Testosterone, Levels Differ between Black and White Men in a Nationally Representative Sample of Americans
Rohrmann et al.
J. Clin. Endocrinol. Metab. 2007;92:2519-2525.
ABSTRACT
| FULL TEXT
Sex Steroids and All-Cause and Cause-Specific Mortality in Men
Araujo et al.
Arch Intern Med 2007;167:1252-1260.
ABSTRACT
| FULL TEXT
Sex Differences in Perceived Risks, Distrust, and Willingness to Participate in Clinical Trials: A Randomized Study of Cardiovascular Prevention Trials
Ding et al.
Arch Intern Med 2007;167:905-912.
ABSTRACT
| FULL TEXT
Review Article: Vascular and Metabolic Effects of Sex Steroids: New Insights Into Clinical Trials
Wierman and Kohrt
Reproductive Sciences 2007;14:300-314.
ABSTRACT
Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002
Thorand et al.
Diabetes Care 2007;30:854-860.
ABSTRACT
| FULL TEXT
Associations of Total Testosterone and Sex Hormone-Binding Globulin Levels With Insulin Sensitivity in Middle-Aged Finnish Men
Rajala et al.
Diabetes Care 2007;30:e13-e13.
FULL TEXT
Endogenous Sex Hormones and Glucose Tolerance Status in Postmenopausal Women
Golden et al.
J. Clin. Endocrinol. Metab. 2007;92:1289-1295.
ABSTRACT
| FULL TEXT
Androgens and Diabetes in Men: Results from the Third National Health and Nutrition Examination Survey (NHANES III)
Selvin et al.
Diabetes Care 2007;30:234-238.
ABSTRACT
| FULL TEXT
Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study
Maggio et al.
Am. J. Physiol. Endocrinol. Metab. 2007;292:E353-E358.
ABSTRACT
| FULL TEXT
FXR: More than a Bile Acid Receptor?
Caron et al.
Endocrinology 2006;147:4022-4024.
FULL TEXT
Obesity and Male Reproductive Potential
Hammoud et al.
J Androl 2006;27:619-626.
FULL TEXT
Endogenous sex hormones and type 2 diabetes risk.
Phillips
JAMA 2006;296:168-169.
FULL TEXT
Endogenous sex hormones and type 2 diabetes risk.
Bondy
JAMA 2006;296:169-169.
FULL TEXT
What's new in the other general journals.
Tonks
BMJ 2006;332:713-714.
FULL TEXT
|
